title: Cytology and mRNA expression analysis of fine needle aspirates of thyroid nodules in an East German region with borderline iodine deficiency.
abstract: Fine needle aspiration cytology (FNAC) is widely recommended as an important tool for pre-operative identification of malignancy in patients with nodular thyroid disease. To assess the diagnostic contribution of FNAC and the potential of quantitative mRNA analysis in fine needle aspirates in daily practice, we conducted a prospective study in thyroid clinics (n=2) and endocrine practices (n=3), respectively in an East German region with borderline iodine deficiency. Two-hundred and forty-four consecutive FNACs were obtained over a period of 2 years (2002-2004) from euthyroid patients presenting for first evaluation of a solitary thyroid nodule. The mean nodule size for FNAC was 27 mm (range: 10-79 mm). In 55% of patients FNAC was performed after scintiscan detection of a cold or normal functioning thyroid nodule (CTN), while in the remainder FNAC was performed as a primary investigation. FNAC outcomes were: 57.8% benign, 22.1% indeterminate, 2.5% suspicious for malignancy, 17.6% non-diagnostic. Messenger RNA levels for a house keeping gene (beta-actin) and a thyroid specific marker (thyroglobulin, Tg) were studied as basic molecular markers using real-time PCR. Both in the IN VIVO and EX VIVO FNA series, beta-actin and Tg mRNA levels were positively correlated with the thyrocyte cell yield/respective FNA smear. However, subgroup analysis showed that FNAC with histologically confirmed follicular thyroid cancer and/or microfollicular adenoma exhibited significantly lower Tg mRNA expression despite high beta-actin levels. Sufficient mRNA quantities were obtained in >90% of FNA specimen to allow quantitative mRNA analysis of at least 5 further genes. In conclusion, quantitative mRNA analysis is feasible in FNA on a routine basis and provides a perspective for a molecular distinction of thyroid nodules, once specific marker genes have been defined for benign and malignant thyroid tumours respectively.
authors.affiliation: III. Medical Department, University of Leipzig, Ph.-Rosenthal-Strasse 27, 04103 Leipzig, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Karger
authors.forename: C
authors.initials: C
authors.lastname: Engelhardt
authors.forename: M
authors.initials: M
authors.lastname: Eszlinger
authors.forename: A
authors.initials: A
authors.lastname: Tönjes
authors.forename: F
authors.initials: F
authors.lastname: Herrmann
authors.forename: P
authors.initials: P
authors.lastname: Müller
authors.forename: Th
authors.initials: T
authors.lastname: Schmidt
authors.forename: C L
authors.initials: CL
authors.lastname: Weiss
authors.forename: H
authors.initials: H
authors.lastname: Dralle
authors.forename: F
authors.initials: F
authors.lastname: Lippitzsch
authors.forename: A
authors.initials: A
authors.lastname: Tannapfel
authors.forename: D
authors.identifier: 0000-0003-0357-4192
authors.initials: D
authors.lastname: Führer
mesh_terms: D000199:Actins / Q000235:genetics; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D044963:Biopsy, Fine-Needle; D005260:Female; D005819:Genetic Markers; D005820:Genetic Testing / Q000379:methods*; D005858:Germany; D006801:Humans; D007430:Intraoperative Care; D007455:Iodine / Q000172:deficiency*; D008297:Male; D008875:Middle Aged; D011182:Postoperative Care; D011300:Preoperative Care; D011446:Prospective Studies; D012333:RNA, Messenger / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013954:Thyroglobulin / Q000235:genetics; D016606:Thyroid Nodule / Q000235:genetics / Q000473:pathology / Q000601:surgery
chemical_list: D000199:Actins; D005819:Genetic Markers; D012333:RNA, Messenger; D013954:Thyroglobulin; D007455:Iodine